Navigation Links
Scientists pinpoint protein that could improve small cell lung cancer therapies
Date:4/22/2014

Approximately 15 percent of all lung cancers are small cell lung cancers (SCLC), which grow rapidly and often develop resistance to chemotherapy. However, researchers at Virginia Commonwealth University Massey Cancer Center have revealed new insights into the mechanisms leading to this resistance that may lead to improved therapies.

Chemotherapies work primarily by mediating B-cell lymphoma 2 (Bcl-2) family proteins, which are responsible for regulating cell death. Depending on their function, this family of proteins can trigger a form of cell suicide known as apoptosis or they can activate mechanisms that prevent apoptosis and promote cell survival. Recently, drugs have been developed that block the function of pro-survival Bcl-2 family proteins. One of these drugs known as ABT-737, and its orally available derivative ABT-263 (currently being tested in clinical trials), has been shown to kill SCLC cells and potentially increase the effectiveness of chemotherapies that affect Bcl-2 family proteins. However, the effectiveness of ABT-737 varies greatly in a broad range of SCLC cells.

In a recent study published in Nature Publishing Group's journal Cell Death & Disease, Massey researchers Hisashi Harada, Ph.D., and Geoffrey Krystal, M.D., Ph.D., discovered that the expression of a protein called Noxa is critical to the effectiveness of ABT-737 because it helps regulate the function of MCL-1, another pro-survival Bcl-2 family protein. Through experiments with cultured SCLC cells, the researchers found that Noxa recruits MCL-1 to the mitochondria, the cell's power producer, which degrades MCL-1 and makes the cancer cells more sensitive to ABT-737.

"Essentially, we discovered how ABT-737 works and why some small cell lung cancer cells are not as affected by it," says Harada, member of the Cancer Cell Signaling research program at Massey and assistant professor in the Philips Institute of Oral and Craniofacial Molecular Biology at the VCU School of Dentistry. "By targeting Noxa, which breaks down MCL-1, we could potentially develop novel small cell lung cancer therapies and help overcome resistance to conventional chemotherapies."

Previous research has shown that Bcl-2 pro-survival family members, like BCL-2 and MCL-1, are over-expressed in SCLC. However, until recently the precise role of these proteins in SCLC biology and therapeutic resistance was poorly understood. When ABT-737 was discovered, it was able to block BCL-2 and another pro-survival protein known as BCL-XL, but not MCL-1. The current research points to the pro-survival functions of MCL-1 as the cause of ABT-737's varied effectiveness.

"Now that we have uncovered Noxa and MCL-1 as potential targets, we can work to better define the mechanisms that help regulate their expression," says Krystal, member of the Developmental Therapeutics research program at Massey, professor of internal medicine in the Division of Hematology, Oncology and Palliative Care and affiliate professor in the Department of Microbiology and Immunology in the VCU School of Medicine, and chair of the Division of Hematology/Oncology at the Hunter Holmes McGuire VA Medical Center. "Moving forward, we plan to conduct additional studies to further define these mechanisms in order to better sensitize small cell lung cancer cells to drugs like ABT-737."


'/>"/>

Contact: Alaina Schneider
afschneider@vcu.edu
804-628-4578
Virginia Commonwealth University
Source:Eurekalert  

Related medicine news :

1. Scientists solving the mystery of human consciousness
2. Scientists uncover multiple faces of deadly breast cancer
3. Scientists identify major source of cells defense against oxidative stress
4. Scientists tailor cell surface targeting system to hit organelle ZIP codes
5. Scientists rewrite rulebook on breast cancer in landmark global study
6. Warwick scientists uncover how checkpoint proteins bind chromosomes
7. NIH scientists link quickly spreading gene to Asian MRSA epidemic
8. Joslin scientists identify important mechanism that affects the aging process
9. Scripps Research scientists show how memory B cells stay in class to fight different infections
10. Scientists Map Melanomas Genome
11. A*STAR scientists discover switch to boost anti-viral response to fight infectious diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists pinpoint protein that could improve small cell lung cancer therapies
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, a ... charity drive to generate community support for efforts to educate the local population on ... for all types of cancer. , Each day in America, roughly 4,600 new ...
(Date:8/18/2017)... ... August 18, 2017 , ... MLM Insurance ... serves communities throughout southern Florida, is working to support the Take Stock In ... from low income families. , The Take Stock In Children Foundation (TSC) offers ...
(Date:8/18/2017)... ... 18, 2017 , ... “Emotions are sacred, valid, honored, encouraged. This is the ... company Generation Mindful. To help change the mindset of parents and educators from punitive ... created the Time-In Toolkit, which launched on Kickstarter 3 weeks ago and fully funded ...
(Date:8/18/2017)... ... August 18, 2017 , ... Inc. magazine has ranked ... most prestigious ranking of the nation's fastest-growing private companies. This marks the eighth time ... Inc. 5000 ranking . This year’s ranking reflects ASH’s 76 percent overall revenue growth ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Three Narrow Roads”: a ... the creation of published author, Rev. Dr. Burnett King Sr., is currently the pastor-teacher-visionary ... founder of the Faith Track Club, Inc., a track-and-field program geared towards youth. , ...
Breaking Medicine News(10 mins):
(Date:8/11/2017)... , Aug. 11, 2017 DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... August 14 and host a conference call at 9:00am ... operating and financial results and its strategy and outlook ... hosted by Erez Raphael , Chief Executive Officer, ...
(Date:8/7/2017)... Insightin Health, provider of data-driven decision-making ... announced the selection of Michael Wood ... as of February 2017. In this role, Wood will ... our clients. Wood brings with him more than ... analytics within the healthcare industry. Wood formerly served ...
(Date:8/7/2017)... 7, 2017  Endo International plc (NASDAQ: ... resolve virtually all known U.S. mesh product liability claims ... the known remaining U.S. claims at reasonable values. Under ... the fourth quarter of 2017 and continuing through the ... quarter 2017 results, the Company intends to increase its ...
Breaking Medicine Technology: